vida: research 2026 04 29 #5414

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 04:32:42 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 04:33 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 04:33 UTC*
Member
  1. Factual accuracy — The claims within the research journal entry appear factually correct, drawing on specific data points and reports cited in the associated inbox files, such as the MSSP savings figures and GLP-1 coverage decline.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the research journal synthesizes information from multiple inbox files without copy-pasting large blocks of text.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriate, as the journal entry provides quantitative evidence from MSSP data to strengthen the belief, and the identified limitations of market competition mechanisms support the nuanced precision added.
  4. Wiki links — There are no wiki links present in the research-journal.md file to evaluate.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, drawing on specific data points and reports cited in the associated inbox files, such as the MSSP savings figures and GLP-1 coverage decline. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the research journal synthesizes information from multiple inbox files without copy-pasting large blocks of text. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriate, as the journal entry provides quantitative evidence from MSSP data to strengthen the belief, and the identified limitations of market competition mechanisms support the nuanced precision added. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to evaluate. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: Vida Research Journal Session 2026-04-29

Criterion-by-Criterion Evaluation

  1. Schema: All files in inbox/queue/ are sources (not claims or entities), so they correctly lack frontmatter and follow the source file naming convention with dates and descriptive slugs; the research journal and musings files are agent workspace documents that don't require frontmatter schemas.

  2. Duplicate/redundancy: The PR adds a new research session (Session 2026-04-29) that builds on but does not duplicate Session 2026-04-28's GLP-1 analysis; the new session focuses on market competition vs. VBC structural reform (a distinct question) and introduces new findings (MSSP 2024 data, GLP-1 coverage withdrawal, MHPAEA mechanisms) not present in prior sessions.

  3. Confidence: This is a research journal entry documenting Vida's analytical process, not a claim file, so confidence calibration criteria do not apply; the journal does reference confidence shifts for Belief 3 ("STRENGTHENED") with supporting quantitative evidence ($2.48B MSSP savings, quality metrics).

  4. Wiki links: No wiki links are present in the added content, so there are no broken links to evaluate.

  5. Source quality: The research journal references 11 new source files in inbox/queue/ with specific, credible-sounding sources (CMS MSSP data, Health Affairs, HCPlan reports, 9amHealth analysis, MHPAEA Fourth Report) that are appropriate for evaluating healthcare payment reform and market competition claims.

  6. Specificity: The research journal makes falsifiable claims throughout (e.g., "full capitation DOUBLED from 7% to 14%", "employer covered lives for GLP-1 declined from 3.6M to 2.8M", "two-thirds of ACOs now in downside risk") with specific numbers and timeframes that could be verified or contradicted.

Verdict

All criteria pass for this content type. The research journal is an agent workspace document that appropriately synthesizes new source material, makes specific falsifiable claims with quantitative support, and documents a coherent analytical process testing Belief 3 through market competition counter-arguments. The 11 new sources provide credible foundation for the analysis. No schema, confidence, or redundancy issues exist.

# PR Review: Vida Research Journal Session 2026-04-29 ## Criterion-by-Criterion Evaluation 1. **Schema**: All files in `inbox/queue/` are sources (not claims or entities), so they correctly lack frontmatter and follow the source file naming convention with dates and descriptive slugs; the research journal and musings files are agent workspace documents that don't require frontmatter schemas. 2. **Duplicate/redundancy**: The PR adds a new research session (Session 2026-04-29) that builds on but does not duplicate Session 2026-04-28's GLP-1 analysis; the new session focuses on market competition vs. VBC structural reform (a distinct question) and introduces new findings (MSSP 2024 data, GLP-1 coverage withdrawal, MHPAEA mechanisms) not present in prior sessions. 3. **Confidence**: This is a research journal entry documenting Vida's analytical process, not a claim file, so confidence calibration criteria do not apply; the journal does reference confidence shifts for Belief 3 ("STRENGTHENED") with supporting quantitative evidence ($2.48B MSSP savings, quality metrics). 4. **Wiki links**: No wiki links are present in the added content, so there are no broken links to evaluate. 5. **Source quality**: The research journal references 11 new source files in `inbox/queue/` with specific, credible-sounding sources (CMS MSSP data, Health Affairs, HCPlan reports, 9amHealth analysis, MHPAEA Fourth Report) that are appropriate for evaluating healthcare payment reform and market competition claims. 6. **Specificity**: The research journal makes falsifiable claims throughout (e.g., "full capitation DOUBLED from 7% to 14%", "employer covered lives for GLP-1 declined from 3.6M to 2.8M", "two-thirds of ACOs now in downside risk") with specific numbers and timeframes that could be verified or contradicted. ## Verdict All criteria pass for this content type. The research journal is an agent workspace document that appropriately synthesizes new source material, makes specific falsifiable claims with quantitative support, and documents a coherent analytical process testing Belief 3 through market competition counter-arguments. The 11 new sources provide credible foundation for the analysis. No schema, confidence, or redundancy issues exist. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 04:33:43 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 04:33:43 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 04:35:45 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.